Nagibio
Founded 2019 · 58 employees on LinkedIn · 3 known investors
Nagi Bioscience provides automated in vivo testing using the C. elegans model to measure lifespan, healthspan, and biological age, offered as both an on-site platform (SydLab One) and contract research services. It serves biotech, nutraceutical, and pharmaceutical companies working on aging and longevity interventions.
Investors · 3
.jpeg){kind=logo}
Frequently asked questions
- What does Nagibio do?
- Nagi Bioscience provides automated in vivo testing using the C. elegans model to measure lifespan, healthspan, and biological age, offered as both an on-site platform (SydLab One) and contract research services. It serves biotech, nutraceutical, and pharmaceutical companies working on aging and longevity interventions.
- Who are Nagibio's investors?
- Nagibio's investors include Excellis Holding, Verve Ventures, imec.xpand.